The future of Italy's hemp sector hangs in the balance after another delay from the European Commission on responding to controversial restrictions adopted or proposed by the Italian government.
This delay comes at a time when hemp-derived goods—especially those low in THC—have become widely accepted and commercially viable across much of Europe, including Italy. Yet, within Italy, the sector now finds itself facing renewed scrutiny and potential legal constraints.
Government Moves to Restrict Hemp Trade and Classify CBD
Two major legislative actions in Italy have triggered alarm among industry stakeholders and rights advocates. The first is a Ministry of Health decree that places certain compositions of CBD obtained from cannabis extracts in section B of the table of narcotic and psychotropic medicines, which would restrict their sale to pharmacies and require a non-repeatable prescription.
The second, a provision in Italy’s proposed Security Bill, aims to prohibit the processing and trade of hemp flowers and derived products—even when they come from hemp varieties within the 0.3% THC limit that EU agricultural rules set for hemp eligible for farm payments.
The decree formally took effect in August 2024 but was suspended by the Lazio Regional Administrative Court in September 2024 pending a final ruling, while the Security Bill provision, already approved by the Chamber of Deputies, was still under review in the Italian Senate at the time of writing. If passed, it would deal a major blow to small-scale farmers and businesses that rely on compliant hemp flower sales for their livelihoods.
Industry Turns to Brussels for Clarity and Protection
In response to these developments, members of Italy’s hemp and CBD sectors have petitioned the European Parliament and called on the European Commission to intervene. The appeal rests on the argument that Italy’s approach contradicts established EU standards, especially regarding hemp with low THC content.
However, during a debate in the European Parliament’s Committee on Petitions on March 17, the Commission said its assessment was still ongoing, noted that neither Italian measure was in force, gave no definitive timeline and expressed no position against Italy.
This delay has left Italian hemp businesses in a state of uncertainty. Many are unsure whether they can continue their operations without risking legal consequences, and new entrants to the industry are holding off until the legal framework becomes clearer.
Stakeholders Warn of Harm to Italy’s Hemp Economy
Industry representatives argue that Italy’s aggressive regulatory approach could cripple the sector’s growth, costing jobs, innovation, and investment. Some of the primary concerns raised include:
- Loss of business for hemp farmers and small-scale producers
- Market instability discouraging both local and foreign investment
- Confusion for consumers and retailers due to inconsistent rules
- Risk of legal challenges if national laws breach EU trade norms
Despite its rich history with hemp cultivation, Italy risks falling behind other European nations that have taken more pragmatic and science-based approaches. Industry leaders are urging the government to revisit the proposed measures and align with broader EU policy frameworks.
Personal Perspective
While ensuring public safety is a legitimate goal, equating certain CBD compositions with narcotic medicines and limiting the hemp flower trade seems counterproductive—especially when these products come from hemp grown within EU THC limits and are widely accepted elsewhere.
It’s hard to ignore the economic implications of these decisions. Italy has the agricultural heritage, expertise, and market interest to lead in this space. But without coherent, balanced regulations, the country risks sidelining itself in an industry poised for significant growth.
I believe the European Commission has a critical role to play here—not just in defending EU norms but in preventing unjust harm to legitimate businesses and consumers.
